Cláudia Maria Padovan

Cláudia Maria Padovan

Auto-generated profile, based on publicly available information

Cláudia Maria Padovan

Universidade de São Paulo

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2022 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
RCRodrigo Campos-Cardoso
Rodrigo Campos-Cardoso
LGLívea Dornela Godoy
Lívea Dornela Godoy
WLWillian Lazarini-Lopes
Willian Lazarini-Lopes
LNLeonardo Santana Novaes
Leonardo Santana Novaes
NSNilton Barreto dos Santos
Nilton Barreto dos Santos
CPCláudia Maria Padovan
Cláudia Maria Padovan

1 September 2021 in Brain Research Bulletin
Verified
Journal Article
Closed access
RMR.B. Malvestio
R.B. Malvestio
PMP. Medeiros
P. Medeiros
SFSylmara Esther Negrini Ferrari
Sylmara Esther Negrini Ferrari
MOM. Oliveira-Silva
M. Oliveira-Silva
AMA.C. Medeiros
A.C. Medeiros
RFRenato Leonardo de Freitas
Renato Leonardo de Freitas

1 February 2014 in Behavioural Brain Research
Verified
Journal Article
Closed access
ALAline P.A.S. Lima
Aline P.A.S. Lima
KSKelly Silva
Kelly Silva
CPCláudia Maria Padovan
Cláudia Maria Padovan
SASebastião Almeida
Sebastião Almeida
MFMarisa Tomoe Hebihara Fukuda
Marisa Tomoe Hebihara Fukuda

1 May 2016 in Alcohol
Verified
Journal Article
Closed access
NGNatália Almeida Gonzaga
Natália Almeida Gonzaga
MBMelissa Resende Batistela
Melissa Resende Batistela
DPDiego Padovan
Diego Padovan
BMBruno Spinosa de Martinis
Bruno Spinosa de Martinis
Carlos R. TirapelliCarlos R. Tirapelli
Carlos R. Tirapelli
CPCláudia Maria Padovan
Cláudia Maria Padovan

1 January 2019 in Behavioural Brain Research
Verified
Journal Article
Closed access
APA.C. Pereira
A.C. Pereira
MCM.C. Carvalho
M.C. Carvalho
CPC.M. Padovan
C.M. Padovan

8 July 2020 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
PDF file
WLWillian Lazarini-Lopes
Willian Lazarini-Lopes
FZFabiana Corsi Zuelli
Fabiana Corsi Zuelli
CPCláudia M Padovan
Cláudia M Padovan
Background: Exposure to stressful aversive situations induces physiological and behavioral changes. Serotonin has been suggested to mediate such changes, as well as adaptation to stressful events. Serotoninergic projections arising from the median raphe nucleus to the dorsal hippocampus have been suggested to promote adaptation to chronic aversive stimuli. Such pathway may involve serotonin type 1a receptor-mediated neurotransmission. However, the serotonin 7 receptor can also be found in the median raphe nucleus and may be involved in mechanisms underlying response to stress. Aims: In this work we sought to investigate if activation of serotonin type 7 receptors would attenuate stress-induced deficits in different animal models of depression. Methods: Male Wistar rats with a guide-cannula aimed to the median raphe nucleus were submitted to restraint or forced swim stress and were tested in an elevated plus maze or forced swim test, respectively, 24 h later. SB 258741 (serotonin type 7 receptor antagonist) and/or LP 44 (serotonin type 7 receptor agonist) were administered intra-median raphe nucleus immediately before or after exposure to stress or before test. Control groups received intra-median raphe nucleus treatment 24 h or immediately before test in the elevated plus maze or forced swim test. Results: LP 44 attenuated restraint-induced exploratory deficits independently of the moment it was administered. Similar results were observed in the forced swim test, with the exception on post-stress condition. These effects on adaptation to stress induced by serotonin type 7 receptor activation were prevented by previous treatment with SB 258741. Conclusions: Our data support the idea that activation of median raphe nucleus serotonin 7 receptor is important to the development of adaptation to stress.